New insights into the structure and function of the plasminogen/plasmin system

Current Opinion in Structural Biology

Volumn 23, Issue 6, 2013, Pages 836-841

  Law, Ruby HP ^a   Abu Ssaydeh, Diana ^a   Whisstock, James C ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; PLASMINOGEN; SERINE PROTEINASE;

AMINO TERMINAL SEQUENCE; BINDING SITE; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CRYPTOCOCCUS NEOFORMANS; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DISEASES; EXTRACELLULAR MATRIX; FIBRIN CLOT; HELICOBACTER PYLORI; HUMAN; MICROBIAL ACTIVITY; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; STRUCTURE ANALYSIS; TISSUE REPAIR; YERSINIA PESTIS;

MALUS X DOMESTICA;

BACTERIAL PHYSIOLOGICAL PHENOMENA; CARBOHYDRATE METABOLISM; DISEASE; FIBRINOLYSIN; HUMANS; PLASMINOGEN;

EID: 84888837321     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2013.10.006     Document Type: Review

References (48)

1. Raum D., et al. Synthesis of human plasminogen by the liver. Science 1980, 208:1036-1037.
2. Zhang L., et al. Plasminogen has a broad extrahepatic distribution. Thromb Haemost 2002, 87:493-501.
3. de Souza L.R., et al. Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasmin. Biochem Biophys Res Commun 2013, 433:333-337.
4. Miles L.A., Castellino F.J., Gong Y. Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. Trends Cardiovasc Med 2003, 13:21-30.
5. Backes B.J., et al. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat Biotechnol 2000, 18:187-193.
6. Barthel D., Schindler S., Zipfel P.F. Plasminogen is a complement inhibitor. J Biol Chem 2012, 287:18831-18842.
7. Kost C., et al. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor. Eur J Biochem 1996, 236:682-688.
8. Daci E., et al. The role of the plasminogen system in bone resorption in vitro. J Bone Miner Res 1999, 14:946-952.
9. Ogiwara K., et al. Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII. Blood Coagul Fibrinolysis 2010, 21:568-576.
10. Pryzdial E.L., et al. Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor. J Biol Chem 1999, 274:8500-8505.
11. Almonte A.G., et al. Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity. J Neurochem 2013, 124:109-122.
12. Samson A.L., et al. Nucleocytoplasmic coagulation: an injuryinduced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasmin. Cell Rep 2012, 2:889-901.
13. Gavrilovic J., Murphy G. The role of plasminogen in cell-mediated collagen degradation. Cell Biol Int Rep 1989, 13:367-375.
14. Santala A., et al. Activation of interstitial collagenase, MMP-1, by Staphylococcus aureus cells having surface-bound plasmin: a novel role of plasminogen receptors of bacteria. FEBS Lett 1999, 461:153-156.
15. Waisman D.M. Plasminogen: Structure, Activation and Regulation 2003, 318. Springer.
16. Miles L.A., Parmer R.J. Plasminogen receptors: the first quarter century. Semin Thromb Hemost 2013, 39:329-337.
17. Iwaki T., et al. The generation and characterization of mice expressing a plasmin-inactivating active site mutation. J Thromb Haemost 2010, 8:2341-2344.
18. Tefs K., et al. Isoelectric focusing pattern of plasminogen mutants of patients with hypoplasminogenemia: correlation of in-vitro data with computer-predicted isoelectric points (pI). Phenotyping by isoelectric focusing gel electrophoresis together with molecular genetic analysis can be used to characterize plasminogen mutation in humans. Blood Coagul Fibrinolysis 2011, 22:499-505.
19. Hiremath M., et al. Heparin in the long-term management of ligneous conjunctivitis: a case report and review of literature. Blood Coagul Fibrinolysis 2011, 22:606-609.
20. Brandt J.T. Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med 2002, 126:1376-1381.
21. Yoo H., et al. A case report on a 18-yr-old male with pulmonary embolism and deep vein thrombosis carrying a heterozygous Ala620Thr plasminogen gene mutation. J Korean Med Sci 2013, 28:959-961.
22. Mingers A.M., et al. Homozygous type I plasminogen deficiency. Semin Thromb Hemost 1997, 23:259-269.
23. Schuster V., Hugle B., Tefs K. Plasminogen deficiency. J Thromb Haemost 2007, 5:2315-2322.
24. Ponting C.P., Marshall J.M., Cederholm-Williams S.A. Plasminogen: a structural review. Blood Coagul Fibrinolysis 1992, 3:605-614.
25. Law R.H., et al. First X-ray crystal structure of human alpha2-antiplasmin publishsed. Blood 2008, 111:2049-2052.
26. Coughlin P.B. Antiplasmin: the forgotten serpin?. FEBS J 2005, 272:4852-4857.
27. Law R.H.P., et al. The X-ray crystal structure of full-length human plasminogen. Cell Rep 2012, 1:185-190.
28. Xue Y., Bodin C., Olsson K. Crystal structure of the native plasminogen reveals an activation-resistant compact conformation. X-ray crystal structure of full-length human plasminogen. J Thromb Haemost 2012, 10:1385-1396.
29. Law R.H., et al. The X-ray crystal structure of full-length human plasminogen.First X-ray crystal structure of human plasminogen publuished. Cell Rep 2012, 1:185-190.
30. Sodetz J.M., Brockway W.J., Castellino F.J. Multiplicity of rabbit plasminogen. Physical characterization. Biochemistry 1972, 11:4451-4458.
31. Hayes M.L., Castellino J.F. Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization. J Biol Chem 1979, 254:8768-8771.
32. Gonzalez-Gronow M., Edelberg J.M., Pizzo S.V. Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site. Biochemistry 1989, 28:2374-2377.
33. McCormack P.L. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012, 72:585-617.
34. Rejante M.R., Llinas M. Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1. Eur J Biochem 1994, 221:939-949.
35. Christensen U., Molgaard L. Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change. Biochem J 1992, 285:419-425.
36. Lay A.J., et al. Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. The glycolytic enzyme phosphoglycerate kinase secreted by fibrosarcoma cells participates in the angiogenic process as a disulphide reductase. Nature 2000, 408:869-873.
37. Horrevoets A.J., et al. The activation-resistant conformation of recombinant human plasminogen is stabilized by basic residues in the amino-terminal hinge region. J Biol Chem 1995, 270:15770-15776.
38. Gong H., et al. A novel PAN/apple domain-containing protein from Toxoplasma gondii: characterization and receptor identification. The PAN/apple domain of a host cell-binding protein of Toxoplasma gondii, P104, may function to facilitate the attachment of this intracellular parasite to host cells during invasion. PLoS ONE 2012, 7:e30169.
39. Stie J., Fox D. Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology 2012, 158:240-258.
40. Ljungh A. Helicobacter pylori interactions with plasminogen. Methods 2000, 21:151-157.
41. Furuya H., Ikeda R. Interaction of triosephosphate isomerase from Staphylococcus aureus with plasminogen. Microbiol Immunol 2011, 55:855-862.
42. Sanderson-Smith M.L., et al. Bacterial plasminogen receptors: mediators of a multifaceted relationship. An overview of the functional role of plasminogen receptors found on the cell surfaces of pathogenic bacteria. J Biomed Biotechnol 2012, 2012. (Article ID: 272148).
43. LeBouder F., et al. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J Gen Virol 2010, 91:2753-2761.
44. Caulfield A.J., Lathem W.W. Substrates of the plasminogen activator protease of Yersinia pestis. An overview of the role of a virulence determinant in plague, plasminogen activator protease (Pla) of Yersinia pestis, in the disruption of the host's coagulation system. Adv Exp Med Biol 2012, 954:253-260.
45. McArthur J.D., et al. The role of streptokinase as a virulence determinant of Streptococcus pyogenes - potential for therapeutic targeting. Curr Drug Targets 2012, 13:297-307.
46. Bergmann S., Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 2007, 98:512-520.
47. Bokarewa M.I., Jin T., Tarkowski A. Staphylococcus aureus: staphylokinase. Int J Biochem Cell Biol 2006, 38:504-509.
48. Wang X., et al. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science 1998, 281:1662-1665.